International Biotechnology Trust – executive interview

International Biotechnology Trust – executive interview

In this interview, we speak with Ailsa Craig and Marek Poszepczynski, portfolio managers at International Biotechnology Trust (IBT), a UK-based investment company that targets innovative biotech companies which address high unmet medical needs, while offering investors the opportunity for financial returns.

Ailsa and Marek provide an overview of IBT, the effect of strong M&A deal flow in recent years on the portfolio’s performance, as well as exciting therapeutic areas to keep an eye on. We also discuss more generally the benefits of gaining exposure to the healthcare sector through an investment company, alongside the potential ramifications following the upcoming US presidential election.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free